Nuclear Factor of Activated T cells 2 (NFAT2), a major anergic regulatory factor downstream of BCR signaling in CLL, maintains the indolent disease phenotype by regulating survival factors such as CD40 Ligand (CD40L) and B Lymphocyte Stimulator (BLYS). This evidence concerns the gene TNFSF13B and B-cell chronic lymphocytic leukemia.